These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 8562940

  • 1. Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia.
    Coustan-Smith E, Kitanaka A, Pui CH, McNinch L, Evans WE, Raimondi SC, Behm FG, Aricò M, Campana D.
    Blood; 1996 Feb 01; 87(3):1140-6. PubMed ID: 8562940
    [Abstract] [Full Text] [Related]

  • 2. Cellular expression of antiapoptotic BCL-2 oncoprotein in newly diagnosed childhood acute lymphoblastic leukemia: a Children's Cancer Group Study.
    Uckun FM, Yang Z, Sather H, Steinherz P, Nachman J, Bostrom B, Crotty L, Sarquis M, Ek O, Zeren T, Tubergen D, Reaman G, Gaynon P.
    Blood; 1997 May 15; 89(10):3769-77. PubMed ID: 9160683
    [Abstract] [Full Text] [Related]

  • 3. In vitro culture with prednisolone increases BCL-2 protein expression in adult acute lymphoblastic leukemia cells.
    Tosi P, Visani G, Ottaviani E, Manfroi S, Tura S.
    Am J Hematol; 1996 Apr 15; 51(4):261-4. PubMed ID: 8602624
    [Abstract] [Full Text] [Related]

  • 4. Prolonged survival of B-lineage acute lymphoblastic leukemia cells is accompanied by overexpression of bcl-2 protein.
    Campana D, Coustan-Smith E, Manabe A, Buschle M, Raimondi SC, Behm FG, Ashmun R, Aricò M, Biondi A, Pui CH.
    Blood; 1993 Feb 15; 81(4):1025-31. PubMed ID: 8427984
    [Abstract] [Full Text] [Related]

  • 5. In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia.
    Hongo T, Yajima S, Sakurai M, Horikoshi Y, Hanada R.
    Blood; 1997 Apr 15; 89(8):2959-65. PubMed ID: 9108416
    [Abstract] [Full Text] [Related]

  • 6. Diversity of the apoptotic response to chemotherapy in childhood leukemia.
    Liu T, Raetz E, Moos PJ, Perkins SL, Bruggers CS, Smith F, Carroll WL.
    Leukemia; 2002 Feb 15; 16(2):223-32. PubMed ID: 11840289
    [Abstract] [Full Text] [Related]

  • 7. CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia.
    Thomas X, Archimbaud E, Charrin C, Magaud JP, Fiere D.
    Leukemia; 1995 Feb 15; 9(2):249-53. PubMed ID: 7532767
    [Abstract] [Full Text] [Related]

  • 8. Molecular diagnosis and clinical relevance of t(9;22), t(4;11) and t(1 ;19) chromosome abnormalities in a consecutive group of 141 adult patients with acute lymphoblastic leukemia.
    Rambaldi A, Attuati V, Bassan R, Neonato MG, Viero P, Battista R, Di Bona E, Rossi G, Pogliani E, Ruggeri M, Amaru R, Rivolta A, Giudici G, Biondi A, Barbui T.
    Leuk Lymphoma; 1996 May 15; 21(5-6):457-66. PubMed ID: 9172811
    [Abstract] [Full Text] [Related]

  • 9. WT1 protein expression in childhood acute leukemia.
    Kerst G, Bergold N, Gieseke F, Coustan-Smith E, Lang P, Kalinova M, Handgretinger R, Trka J, Müller I.
    Am J Hematol; 2008 May 15; 83(5):382-6. PubMed ID: 18161786
    [Abstract] [Full Text] [Related]

  • 10. Increased BAX expression is associated with an increased risk of relapse in childhood acute lymphocytic leukemia.
    Hogarth LA, Hall AG.
    Blood; 1999 Apr 15; 93(8):2671-8. PubMed ID: 10194447
    [Abstract] [Full Text] [Related]

  • 11. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
    Tzortzatou-Stathopoulou F, Papadopoulou AL, Moschovi M, Botsonis A, Tsangaris GT.
    J Pediatr Hematol Oncol; 2001 Dec 15; 23(9):591-7. PubMed ID: 11902303
    [Abstract] [Full Text] [Related]

  • 12. Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation.
    Uckun FM, Herman-Hatten K, Crotty ML, Sensel MG, Sather HN, Tuel-Ahlgren L, Sarquis MB, Bostrom B, Nachman JB, Steinherz PG, Gaynon PS, Heerema N.
    Blood; 1998 Aug 01; 92(3):810-21. PubMed ID: 9680349
    [Abstract] [Full Text] [Related]

  • 13. The role of breast cancer resistance protein in acute lymphoblastic leukemia.
    Plasschaert SL, van der Kolk DM, de Bont ES, Kamps WA, Morisaki K, Bates SE, Scheffer GL, Scheper RJ, Vellenga E, de Vries EG.
    Clin Cancer Res; 2003 Nov 01; 9(14):5171-7. PubMed ID: 14613996
    [Abstract] [Full Text] [Related]

  • 14. Expression of BCL-2 proto-oncogene in adult acute lymphoblastic leukemia.
    Campos L, Sabido O, Sebban C, Charrin C, Bertheas MF, Fière D, Guyotat D.
    Leukemia; 1996 Mar 01; 10(3):434-8. PubMed ID: 8642858
    [Abstract] [Full Text] [Related]

  • 15. Simultaneous detection of MDR1 and WT1 gene expression to predict the prognosis of adult acute lymphoblastic leukemia.
    Xu B, Song X, Yip NC, Xiao P, Zhang Y, Wang W, Zhou S.
    Hematology; 2010 Apr 01; 15(2):74-80. PubMed ID: 20423567
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Bcl-2 expression in acute myeloblastic leukaemia: relationship with autonomous growth and CD34 antigen expression.
    Bradbury DA, Zhu YM, Russell NH.
    Leuk Lymphoma; 1997 Jan 01; 24(3-4):221-8. PubMed ID: 9156652
    [Abstract] [Full Text] [Related]

  • 19. Expression and regulation of Bcl-2, Bcl-xl, and Bax correlate with p53 status and sensitivity to apoptosis in childhood acute lymphoblastic leukemia.
    Findley HW, Gu L, Yeager AM, Zhou M.
    Blood; 1997 Apr 15; 89(8):2986-93. PubMed ID: 9108419
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.